Seroquel (quetiapine) is an atypical antipsychotic medication that works primarily by blocking serotonin and dopamine receptors in the brain. It’s FDA-approved to treat schizophrenia, bipolar disorder (both manic and depressive episodes), and as an add-on treatment for major depressive disorder. It’s also one of the most commonly prescribed psychiatric medications off-label, particularly for sleep.
How Seroquel Works in the Brain
Seroquel targets two key neurotransmitter systems: serotonin and dopamine. What makes it “atypical” compared to older antipsychotics is its strong preference for blocking serotonin receptors over dopamine receptors. At standard doses (300 mg/day and above), it significantly blocks serotonin receptors in the brain’s cortex while maintaining relatively low blockade of dopamine receptors in the movement-control areas of the brain. This balance is important because heavy dopamine blockade in those areas causes the stiffness, tremors, and involuntary movements that made older antipsychotic drugs so difficult to tolerate.
At lower doses (under 100 mg), Seroquel acts differently. It primarily blocks histamine receptors, which is why low doses cause strong sedation without much antipsychotic effect. This dose-dependent behavior explains why it gets prescribed at such different doses for different purposes.
Approved Uses
The FDA has approved Seroquel for several specific conditions:
- Schizophrenia in adults and adolescents ages 13 to 17
- Manic episodes in bipolar I disorder, either alone or alongside mood stabilizers, in adults and children ages 10 to 17
- Depressive episodes in bipolar I and bipolar II disorder in adults
- Maintenance treatment of bipolar I disorder as an add-on to mood stabilizers in adults
- Major depressive disorder as an add-on to an antidepressant in adults
For bipolar depression specifically, Seroquel can begin working faster than many people expect. Research published in the Journal of Clinical Psychopharmacology found that the extended-release version showed measurable improvement within the first three days of treatment, with reductions in most depression symptoms except physical anxiety. Full effects typically build over several weeks, but that early response can be reassuring for people starting the medication during a depressive episode.
Off-Label Use for Sleep
One of the most common reasons people take Seroquel is for insomnia, even though it isn’t approved for this purpose. Doctors frequently prescribe it at low doses, typically 25 to 200 mg at bedtime, well below the 150 to 800 mg range used for its approved conditions. The sedation comes from its strong histamine-blocking effect, which kicks in at these lower doses.
This practice is controversial. A review of the available safety data concluded that low-dose quetiapine for insomnia is “not recommended” based on limited evidence and real safety concerns. While short-term side effects in studies were relatively minor (drowsiness and dry mouth), longer-term studies found significant weight gain even at these lower doses. Case reports have also documented serious complications including liver damage, restless legs syndrome, and a type of inner restlessness called akathisia. The concern is that patients are taking on the metabolic risks of an antipsychotic to treat a condition that has safer, better-studied alternatives.
Immediate Release vs. Extended Release
Seroquel comes in two formulations that behave quite differently in the body. The immediate-release (IR) version reaches peak levels in about 2 hours, which is why it causes noticeable sedation relatively quickly. The extended-release (XR) version takes 5 to 6 hours to peak, releasing the drug gradually and producing a smoother, more sustained effect throughout the day.
The XR version is generally taken once daily, while IR may be taken two or three times per day depending on the condition being treated. Your doctor will choose between them based on what you’re being treated for and how you respond to the medication.
Side Effects and Metabolic Risks
Seroquel’s most significant long-term concern is its effect on metabolism. Even at low doses, it causes measurable weight gain. A 2025 meta-analysis found that patients on low-dose quetiapine gained an average of about 0.6 kg more than those on placebo, and were roughly twice as likely to gain 7% or more of their body weight. Low doses also reduced HDL (“good”) cholesterol levels. At the higher doses used for schizophrenia and bipolar disorder, these metabolic effects are more pronounced and include increased risks of elevated blood sugar and cholesterol.
Common side effects that people notice day to day include drowsiness (especially when starting or increasing the dose), dry mouth, dizziness when standing up, and constipation. The sedation often decreases after the first week or two as the body adjusts, though some people continue to feel groggy in the morning.
Serious Safety Warnings
Seroquel carries an FDA boxed warning, the most serious type, about use in elderly patients with dementia-related psychosis. An analysis of 17 placebo-controlled trials found that elderly dementia patients treated with atypical antipsychotics had 1.6 to 1.7 times the risk of death compared to those on placebo. Over a typical 10-week trial, 4.5% of drug-treated patients died compared to 2.6% on placebo. Deaths were primarily cardiovascular (heart failure, sudden death) or infectious (pneumonia). Seroquel is not approved for treating dementia-related psychosis.
Stopping Seroquel abruptly can cause withdrawal symptoms including insomnia, nausea, and irritability. If you and your doctor decide to discontinue it, the dose is typically tapered gradually over several weeks rather than stopped all at once.
What to Expect When Starting
Most people notice sedation from the very first dose. This is normal and often the most obvious initial effect. For psychiatric conditions, the therapeutic benefits take longer to appear. While some improvement in bipolar depression may begin within days, the full effect on psychotic symptoms, mood stabilization, or depressive episodes generally develops over two to six weeks.
Doctors typically start at a low dose and increase gradually over the first week to reduce side effects like dizziness and excessive sedation. Maintenance doses for bipolar disorder range from 400 to 800 mg/day, while doses for schizophrenia vary based on individual response. Blood work to monitor blood sugar, cholesterol, and liver function is standard during treatment, particularly in the first few months.